Common Contracts
2 similar Exclusive License Agreement contracts by Applied Genetic Technologies Corp
EX-10.2 5 d615962dex102.htm EX-10.2 Agreement No. 2001-09-13B EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMS (Alpha-1- Anti-Trypsin UF#184I) Exhibit A - Development Report Exhibit B - Equity Agreement Exhibit C - Acknowledgment and Consent...Exclusive License Agreement • May 5th, 2020
This Agreement is made effective the 25th day of September, 2001, (the “Effective Date”) by and between the University of Florida Research Foundation, Inc. (hereinafter called “UFRF”), a nonstock, nonprofit Florida corporation, and Applied Genetic Technologies Corporation (hereinafter called “Licensee” or “AGTC”), a corporation organized and existing under the laws of Florida. Licensee shall include any wholly owned subsidiary of AGTC.
EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMS (Alpha-1- Anti-Trypsin UF#184I)Exclusive License Agreement • November 4th, 2013 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
This Agreement is made effective the 25th day of September, 2001, (the “Effective Date”) by and between the University of Florida Research Foundation, Inc. (hereinafter called “UFRF”), a nonstock, nonprofit Florida corporation, and Applied Genetic Technologies Corporation (hereinafter called “Licensee” or “AGTC”), a corporation organized and existing under the laws of Florida. Licensee shall include any wholly owned subsidiary of AGTC.
